Possis Medical, Inc. has received clearance from the FDA to market its AngioJet Xpeedior catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. Used with the company’s AngioJet System, Xpeedior is the only device cleared for thrombectomy in peripheral veins.
Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...
Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of “Heart Rhythm.”
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
AngioDynamics, Inc. has announced FDA 510(k) clearance for Oncobionic, Inc. to market Irreversible Electroporation (IRE) ...
The FDA has cleared Toshiba's new EXCELART Vantage Atlas 1.5T MRI system, which the company showcased this week during ...
An innovative lead insulation material for cardiac leads used with pacemakers and ICDs is now FDA approved and available ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The New York Academy of Medicine in New York, NY. The three-day program is dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration.
GE Healthcare has launched its new LightSpeed VCT XT, the industry’s first CT scanner that maintains outstanding image ...
An implantable technology to control high blood pressure in patients not responding to available medicines has ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Houston based ThromboVision, Inc. has won the first annual Michael E. DeBakey Life Science Award, which carries a $50,000 cash prize to assist in propelling the company's technology toward commercial success.
November 2006 - Toshiba America Medical Systems, Inc. has announced a new partnership with CVCTA Education and San ...
In its third quarter financial report, San Diego-based Cytori said it has moved significantly closer to initiating its cardiovascular clinical trials," said Christopher J. Calhoun, chief executive officer of Cytori Therapeutics. The company is developing adipose stem cells in cardiovascular disease and for use in reconstructive surgery.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
A German physician reports that people who have implanted pacemakers or defibrillators are not in danger of their ...
The stent market will have a distinctly different look after Johnson & Johnson completes its acquisition of Conor ...
A guide wire-based occlusion device, the GuardDOG by Possis Medical enables physicians to quickly and effectively manage local blood flow while employing interventional techniques and devices to treat vascular disease. It features a 0.035-inch diameter guide wire, preferred for peripheral interventions, and a soft, compliant, CO2-filled balloon providing quick inflation and deflation.